Is MPV a Real Prognostic Indicator for Non-small Cell Lung Cancer?

  • Ozyalvacli, Gulzade (Department of Pathology, Faculty of Medicine, Abant Izzet Baysal University) ;
  • Yasar, Zehra (Department of Chest Diseases, Faculty of Medicine, Abant Izzet Baysal University)
  • Published : 2014.10.11




  1. Cengiz C, Erhan Y, Murat T, et al (2013). Values of mean platelet volume in patients with chronic tonsillitis and adenoid hypertrophy. Pak J Med Sci, 29, 569-72.
  2. Gwak MS, Choi SJ, Kim JA, et al (2007). Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci, 22, 104-8.
  3. Inagaki N, Kibata K, Tamaki T, et al (2014). Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer, 83, 97-101.
  4. Karagoz B AA, Bilgi O, et al (2009). Platelet count and platelet distribution width increase in lung cancer patients. Anatol J Clin Investig, 3, 32-4.
  5. Kemal Y, Yucel I, Ekiz K, et al (2014). Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev, 15, 2651-4.
  6. Lance MD, Sloep M, Henskens YM, et al (2012). Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost, 18, 561-8.
  7. Vizioli L, Muscari S, Muscari A (2009). The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract, 63, 1509-15.
  8. Walsh SR, Cook EJ, Goulder F, et al (2005). Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4.